Trials / Conditions / Superficial Basal Cell Carcinoma

Superficial Basal Cell Carcinoma

18 registered clinical trials studyying Superficial Basal Cell Carcinoma — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	High Intensity Focused Ultrasound vs. Cryotherapy in the Treatment of Basal Cell Carcinomas and Bowen's Diseas NCT07384078	Jussi Salonen	N/A
Completed	Proof of Concept Study to Access Superficial Basal Cell Carcinoma in Adults NCT05713760	Austin Institute for Clinical Research	Phase 2
Recruiting	5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer NCT05381597	Boston University	Phase 2 / Phase 3
Recruiting	A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma NCT05157763	MediWound Ltd	Phase 1 / Phase 2
Active Not Recruiting	Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma NCT04744935	Christopher Zachary	N/A
Completed	Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma NCT04552990	Memorial Sloan Kettering Cancer Center	Phase 2
Completed	Safety and Efficacy Evaluation of AIV001 in Nonmelanoma Skin Cancer of the Low Risk Basal Cell Carcinoma Subty NCT04470726	AiViva BioPharma, Inc.	Phase 1 / Phase 2
Active Not Recruiting	Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superfi NCT03573401	Biofrontera Inc.	Phase 3
Completed	A Patient Decision Aid for Patients With Superficial Basal Cell Carcinoma NCT05628714	Maastricht University Medical Center	—
Completed	Randomized Pilot Study of Treatment for BCC Using the Multiplex 595/1064 nm Laser NCT02270645	University of Miami	N/A
Completed	Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled NCT03012009	University Hospital, Ghent	N/A
Unknown	Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulini NCT01491711	Maastricht University Medical Center	Phase 4
Completed	PEP005 Gel - Evaluation of the Safety and Efficacy of Ingenol Mebutate Gel on a Superficial Basal Cell Carcino NCT01325688	Peplin	Phase 2
Terminated	Cure Rates of Superficial Basal Cell Carcinoma (BCC) EDC NCT00994240	University of Wisconsin, Madison	N/A
Completed	Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell NCT00604890	BPGbio	Phase 1 / Phase 2
Completed	To Determine the Maximum Tolerated Dose Level (MTD) of PEP005 Topical Gel in Patients With sBCC NCT00432185	Peplin	Phase 2
Completed	Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream NCT00189306	Graceway Pharmaceuticals, LLC	Phase 3
Completed	Metvix Photodynamic Therapy (PDT) Versus Cryotherapy in Participants With Primary Superficial Basal Cell Carci NCT00469417	Galderma R&D	Phase 3